Your browser doesn't support javascript.
loading
Evaluating nuclear translocation of surface receptors: recommendations arising from analysis of CD44.
Thorne, Rick F; Wang, Yan; Zhang, Yan; Jing, Xueli; Zhang, Xu Dong; de Bock, Charles E; Oliveira, Camila S.
Afiliação
  • Thorne RF; Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450053, China. rick.thorne@newcastle.edu.au.
  • Wang Y; School of Environmental and Life Sciences, University of Newcastle, Callaghan, NSW, 2308, Australia. rick.thorne@newcastle.edu.au.
  • Zhang Y; Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450053, China.
  • Jing X; Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450053, China.
  • Zhang XD; Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450053, China.
  • de Bock CE; Translational Research Institute, Henan Provincial People's Hospital, Academy of Medical Science, Zhengzhou University, Zhengzhou, 450053, China.
  • Oliveira CS; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, 2308, Australia.
Histochem Cell Biol ; 153(2): 77-87, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31834485
ABSTRACT
CD44 is a transmembrane receptor that acts as adhesion protein, fundamentally recognizing hyaluronan, an essential component of the extracellular matrix. It has a well-established functional association with cancer metastasis, particularly the CD44 variant forms which are considered essential markers of cancer stem cells. CD44 itself lacks intrinsic kinase activity but rather engages in signalling through specific interactions with kinases and other signalling components. Proteolysis within its transmembrane region also leads to release of the CD44 cytoplasmic domain, which can translocate to the nucleus and regulate transcription. A third signalling modality has been reported where the intact CD44 receptor translocates to the nucleus. Here, we investigated the latter using imaging techniques together with biochemical analyses. Our findings support observations where CD44 is cleaved prior to nuclear translocation and challenges the evidence for the presence of intact CD44 receptors in the cell nucleus. Conclusions regarding the presence of intact CD44 in the cell nucleus as a signalling modality, therefore, require re-evaluation. We highlight artefacts and common technical issues associated with these experiments that can lead to misinterpretation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Núcleo Celular / Receptores de Superfície Celular / Receptores de Hialuronatos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Núcleo Celular / Receptores de Superfície Celular / Receptores de Hialuronatos Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article